Therapeutics: Angiotensin II type 1 receptor (AGTR1)

Cancer

INDICATION: Pancreatic cancer

Patient sample and mouse studies suggest AGTR1 inhibitors could help sensitize obese pancreatic ductal adenocarcinoma (PDAC) patients

Read the full 192 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE